DIVI'S LABORATORIES LTD. - 532488 - Disclosure Under Regulation 30 Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015
As per enclsoed letter.16-11-2023
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of earnings conference call held on November 06, 2023.11-11-2023
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication07-11-2023
Divis Lab Share Price Live blog for 07 Nov 2023
Divis Lab stock price went up today, 07 Nov 2023, by 4.65 %. The stock closed at 3349.9 per share. The stock is currently trading at 3505.7 per share. Investors should monitor Divis Lab stock price closely in the coming days and weeks to see how it reacts to the news.07-11-2023
Divis Laboratories Q2 net down 29% at 348 cr
Total revenue grew 3 per cent at 1,909 crore06-11-2023
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
As per enclosed.06-11-2023
Divi's Laboratories Results Earnings Call for Q2FY24
Conference Call with Divi's Laboratories Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.06-11-2023
Q2FY24 Quarterly & H1FY24 Bi-Annual Result Announced for Divi's Laboratories Ltd.
Pharmaceuticals company Divi's Laboratories announced Q2FY24 & H1FY24 results: Q2FY24: Total income for Q2FY24 increased from Rs 1,935 crore to Rs 1,995 crore in Q2FY23. PBT for Q2FY24 decreased from Rs 615 crore to Rs 469 crore in Q2FY23. PAT for Q2FY24 decreased from Rs 493 crore to Rs 348 crore in Q2FY23. Forex Gain of Rs 11 crore compared to Rs 31 crore in Q2FY23 H1FY24: Total income for H1FY24 decreased from Rs 4,278 crore to Rs 3,854 crore in H1FY23. PAT for H1FY24 decreased from Rs 1,196 crore to Rs 704 crore in H1FY23. Forex Gain of Rs 14 crore compared to Rs 87 crore in H1FY23. Result PDF06-11-2023